rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter

NCT00145366 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Benign Nontoxic and Toxic Goiter
Graves' Disease

Interventions

DRUG: Recombinant human thyrotropin (Thyrogen)

Sponsor

Odense University Hospital